cramer: this biotech stock could be worth over $100 billion on an fda approval
Published 4 years ago • 408K plays • Length 5:19Download video MP4
Download video MP3
Similar videos
-
1:04
an fda approval could be worth over $100 billion to this biotech stock
-
1:22
cramer remix: this could be the hottest biotech stock of the year
-
1:50
jim cramer: there will be push back on biogen's alzheimer's drug price
-
3:29
jim cramer: how inflation affects stocks of alphabet, microsoft and apple
-
1:10
jim cramer: we're taking profits in amd
-
bloomberg business news live
-
6:34
there's valuation opportunities here for china, says neuberger berman's conrad saldanha
-
43:49
intel rebuffs arm, china tech stocks soar | bloomberg technology
-
6:16
cramer: never buy a stock all at once — you'll almost definitely get burned
-
3:00
jim cramer on how investors should handle stay-at-home stock slump on pfizer vaccine news
-
12:07
cramer takes on the bull and bear debate over a.i.
-
4:01
cramer weighs in on the week for stocks
-
3:03
jim cramer: vertex pharma 'dinged' after dem debate, sets up a 'buyable dip'
-
11:32
jim cramer says to consider an analysts' call timeframe when investing
-
6:42
cramer: never buy a stock all at once — you'll almost definitely get burned
-
3:31
cramer explains why this upcoming earnings season could be 'brutal' for some sectors of the market
-
2:57
jim cramer: tesla could be like amazon, and there is no second amazon
-
8:47
jim cramer's guide to finding bulletproof stocks using charts
-
11:33
jim cramer breaks down how sectors are performing in the economy
-
7:47
jim cramer: tesla’s pullback was inevitable, but the stock remains ‘too legit to quit’
-
4:17
jim cramer on why he thinks xilinx may not be ready to sell to amd
-
9:04
jim cramer offers an explanation for ev start-up rivian reaching $86 billion market cap